Results 111 to 120 of about 351,529 (205)

Generic Drug Usage in Dentistry across Japan: Analysis Using a Japanese National Database. [PDF]

Int J Environ Res Public Health, 2021
Ono S, Komatsuzaki A, Iguchi A, Kikuchi H, Motoi S, Susuga M.   +5 more
europepmc   +1 more source

Deep Dive into Generic Drug Applications to Seek Harmonization of Bioequivalence Criteria for Narrow Therapeutic Index Drugs. [PDF]

Pharm Res
Mina M, Zhang Z, Sun W, Anim Anno K, Zhang L, Jiang W.   +5 more
europepmc   +1 more source

Physician dispensing and the choice between generic and brand-name drugs – Do margins affect choice? [PDF]

Many politicians blame physician dispensing (PD) to increase health care expenditure and to undermine independence of drug prescription and income leading to a suboptimal medication. Therefore, PD is not allowed in most OECD countries. In Switzerland, PD
Maria Trottmann, Maurus Rischatsch
core  

Mechanisms influencing generic drug substitution behavior under the national centralized drug procurement policy. [PDF]

J Pharm Policy Pract
Lin F, Li H, Zhu K, Wu Y, Fan Q, Ding J, Li W.   +6 more
europepmc   +1 more source

Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug Manufacturer. [PDF]

Pharmacoecon Open
Sertkaya A, El-Kilani Z, Klein S, Lord A, Jacobo-Rubio R, Parasrampuria S.   +5 more
europepmc   +1 more source

Pharmacokinetics and Generic Drug Switching: A Regulator's View. [PDF]

Clin Pharmacokinet, 2020
Glerum PJ, Neef C, Burger DM, Yu Y, Maliepaard M.   +4 more
europepmc   +1 more source

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey [PDF]

The nation's spending for prescription drugs has grown dramatically in recent years. Previous studies have shown that the replacement of older drugs by newer, more expensive, drugs is the single most important reason for this increase, but they did not ...
Frank Lichtenberg
core  

Breaking brand: an observational study on pharmacy-hospital-patient relationships and generic drug utilisation in Japan. [PDF]

BMJ Open
Fujimoto A, Fu R, Noguchi H, Maruyama S, Nakamura S.   +4 more
europepmc   +1 more source

A Physician's Perspective on Generic Drug Quality. [PDF]

J Manag Care Spec Pharm, 2020
Lever HM.
europepmc   +1 more source

The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent. [PDF]

J Gen Intern Med, 2022
Miller D, Ippolito B, Hernandez I, Davies B.   +3 more
europepmc   +1 more source